Readmission after atrial fibrillation ablation-Can we prevent the "bounce back"?

J Cardiovasc Electrophysiol

Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina, USA.

Published: April 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1111/jce.15865DOI Listing

Publication Analysis

Top Keywords

readmission atrial
4
atrial fibrillation
4
fibrillation ablation-can
4
ablation-can prevent
4
prevent "bounce
4
"bounce back"?
4
readmission
1
fibrillation
1
ablation-can
1
prevent
1

Similar Publications

The effect of 0.5 mg dose of colchicine on clinical outcomes in patients with acute myocardial infarction: An updated meta-analysis of randomized controlled trials.

Curr Probl Cardiol

September 2025

Medical Research Group of Egypt (MRGE), Negida Academy, Arlington, MA, USA; Faculty of Medicine, Kafr-Elsheikh University, Kafr-Elsheikh, Egypt; Faculty of Medicine, Al-Azhar University, Cairo, Egypt; Institute of Medicine, National Research Mordovia State University, Saransk, Russia; Faculty of Med

Background: Inflammation plays a critical role in the progression of atherosclerosis, and the anti-inflammatory effects on clinical outcomes of patients with acute myocardial infarction (AMI) are still uncertain.

Objectives: We aimed to study the effects of a 0.5 mg dose of colchicine on clinical outcomes following AMI.

View Article and Find Full Text PDF

Timing, Diagnosis, and Potential Preventability of 30-Day Unplanned Readmissions After a Heart Failure Hospitalisation: Implications for Care Quality.

Heart Lung Circ

September 2025

Department of Cardiology, The Prince Charles Hospital, Brisbane, Qld, Australia; School of Medicine, Faculty of Medicine, The University of Queensland, Brisbane, Qld, Australia.

Aim: To assess timing, causes, and potential preventability of unplanned readmissions within 30 days of heart failure hospitalisation and how they vary by age and sex across the population.

Method: We conducted a cohort study using hospitalisation data from 2013 to 2017 from all public and most private hospitals in Australia and New Zealand, including 197,648 patients aged ≥18 years (mean age 78.2 [standard deviation 12.

View Article and Find Full Text PDF

Transthoracic echocardiography (TTE) at the time of acute decompensated heart failure (ADHF) may reveal significant structural and hemodynamic abnormalities that can guide clinical management. However, the impact of routine repeat TTE in uncomplicated ADHF re-admissions is yet to be established. We studied patients with repeat TTE at the time of rehospitalization for ADHF to determine downstream clinical impact.

View Article and Find Full Text PDF

Background: Transcatheter left atrial appendage occlusion (LAAO) has become a suitable alternative to anticoagulation in patients with atrial fibrillation (AF). However, outcomes among patients age > 75 years undergoing LAAO are lacking.

Methods: We included 723 consecutive patients with AF undergoing LAAO from August 2015 to March 2020.

View Article and Find Full Text PDF

Heart failure (HF) is the end-stage of all cardiac diseases, characterized by high prevalence, high mortality, and heavy social and economic burden. Early warning of HF exacerbation is of great value for outpatient management and reducing readmission rates. Currently, remote dynamic monitoring technology, which captures changes in hemodynamic and physiological parameters of HF patients, has become the primary method for early warning and is a hot research topic in clinical studies.

View Article and Find Full Text PDF